The medical and pharmaceutical community continues to embrace emerging technologies, beginning with mRNA that rose to fame during the COVID-19 pandemic. The beauty of mRNA technology is that it opens ...

CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...

Moderna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again on the move — in a good way. The stock is up 68% over the past six months, with partnerships around ...

Moderna (MRNA) faces major commercial setbacks as mRNA vaccines underperform against traditional competitors in post-pandemic markets. RSV and flu mRNA vaccines struggle with lower durability, higher ...

Messenger RNA vaccines aren’t just saving human lives—they are protecting elephants as well. In 2024, Tess, an elephant at the Houston Zoo, became the first to receive an mRNA vaccine developed by ...

A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of ...

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) ...